<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02217605</url>
  </required_header>
  <id_info>
    <org_study_id>A32006_FRU</org_study_id>
    <nct_id>NCT02217605</nct_id>
  </id_info>
  <brief_title>31P Magnetic Resonance Spectroscopy Fructose Study</brief_title>
  <acronym>31PMRS_FRU</acronym>
  <official_title>Investigating the Effects of an Oral Fructose Challenge on Hepatic ATP Reserves in Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stephen Bawden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Biotechnology and Biological Sciences Research Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Unilever R&amp;D</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Nottingham</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effects of an oral fructose challenge on liver
      adenosine triphosphate (ATP) reserves using 31P magnetic resonance spectroscopy (MRS) as a
      potential measure measure of liver health.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study uses 31P spectra acquired from the liver in healthy subjects following a fructose
      drink to monitor ATP levels. This is also related to baseline BMI, liver glycogen and liver
      lipid levels
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hepatic ATP reserves following an oral fructose challenge</measure>
    <time_frame>2 hours post prandial</time_frame>
    <description>Monitor hepatic ATP levels following an oral fructose challenge using 31P magnetic resonance spectroscopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlate hepatic ATP depletion / recovery with BMI, liver lipids and liver glycogen</measure>
    <time_frame>2 hours post prandial</time_frame>
    <description>Measure baseline liver lipid and glycogen using magnetic resonance spectroscopy and correlate BMI, lipid and glycogen levels with rate of ATP depletion and recovery following an oral fructose challenge</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Fructose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral Fructose Challenge (75 g fructose in 500 ml water) followed by 75 minutes 31P MRS</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fructose</intervention_name>
    <description>Oral Fructose Challenge (75 g fructose in 500 ml water) following overnight fast</description>
    <arm_group_label>Fructose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male

          -  Age 18 - 30

          -  BMI 20 - 27 kg/m^2

          -  Healthy

        Exclusion Criteria:

          -  Smokers

          -  Liver disease or Metabolic Disorders

          -  Metal implants (not suitable for MRI)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luca Marciani</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Nottingham</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Nottingham</name>
      <address>
        <city>Nottingham</city>
        <state>Nottinghamshire</state>
        <zip>NG7 2RD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 12, 2014</study_first_submitted>
  <study_first_submitted_qc>August 14, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 15, 2014</study_first_posted>
  <last_update_submitted>August 14, 2014</last_update_submitted>
  <last_update_submitted_qc>August 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 15, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Nottingham</investigator_affiliation>
    <investigator_full_name>Stephen Bawden</investigator_full_name>
    <investigator_title>CASE studentship researcher</investigator_title>
  </responsible_party>
  <keyword>NAFLD</keyword>
  <keyword>Oral Fructose Challenge</keyword>
  <keyword>31P MRS</keyword>
  <keyword>Liver</keyword>
  <keyword>Subjects</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

